Trials / Completed
CompletedNCT04477447
PMCF Study on the Safety and Performance of CESPACE 3D
Multicenter PMCF Study on the Safety and Performance of CESPACE 3D - A Prospective Study on Total Indications
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 101 (actual)
- Sponsor
- Aesculap AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, pure data collection of all CeSPACE 3D patients in selected centers (not interventional, multicenter)
Conditions
Timeline
- Start date
- 2020-09-21
- Primary completion
- 2023-06-13
- Completion
- 2024-04-16
- First posted
- 2020-07-20
- Last updated
- 2024-12-19
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT04477447. Inclusion in this directory is not an endorsement.